Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by University of California, Davis
Sponsor:
Collaborator:
Lawrence Livermore National Laboratory
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01261299
First received: December 9, 2010
Last updated: September 15, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)